Press Release

Oracle Buys Intellectual Property Assets of Conformia

Redwood Shores, Calif.—Jun 17, 2009


News Facts

  • Today Oracle announced that it has acquired the intellectual property assets of Conformia Software.
  • Conformia’s Product and Process Lifecycle Management (PPLM) software has unique capabilities for Life Sciences companies to manage drug design, development and transfer to production across Bio, Pharmaceutical and Chemical drug components.
  • Oracle plans to integrate Conformia’s product and technology into Oracle Agile PLM solution to offer an end-to-end solution for managing drug development, packaging and commercialization.
  • Oracle plans to provide integrations to Oracle applications, Oracle Health Sciences applications and 3rd party systems.
  • This combination will enable Pharmaceutical and Bio-technology companies to accelerate innovation, meet regulatory objectives and improve productivity.
  • Financial details of the transaction were not disclosed.
    • “The addition of Conformia Software technology underscores Oracle’s commitment to provide customers with a differentiated, out-of-box industry-based solution," said Oracle Vice President of PLM Strategy Hardeep Gulati. "Oracle’s PLM offering will give our Life Sciences industry customers a complete solution to manage drug design, development to commercialization.”

Contact Info
Susie Penner
Oracle Public Relations
+1.650.506.1973
susanne.penner@oracle.com
Ken Bond
Oracle Investor Relations
+1.650.506.4073
ken.bond@oracle.com
About Oracle

Oracle engineers hardware and software to work together in the cloud and in your data center. For more information about Oracle (NYSE:ORCL), visit www.oracle.com.

Trademarks

Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.


Talk to a Press Contact

Susie Penner

  • +1.650.506.1973

Ken Bond

  • +1.650.506.4073